Evidence map›Paper›PMID 42452142›Full record

ArticlePlants (Basel, Switzerland)2026

A Dual-Side Synergistic LoRA Framework for Full-Chain Fine-Tuning of Qwen2.5-VL for Plant Disease Diagnosis.

Zhengyan Zhang, Quan Feng

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhengyan ZhangCollege of Mechanical and Electrical Engineering, Gansu Agricultural University, Lanzhou 730070, China.
Quan FengCollege of Mechanical and Electrical Engineering, Gansu Agricultural University, Lanzhou 730070, China.

Funding

Gansu Education Department 2021CYZC-57National Natural Science Foundation of China No.32160421,No.32201663
6 · The paper itself

Abstract

The emergence of multimodal large language models (MLLMs) is opening a new avenue for explainable and interactive intelligent diagnosis in agriculture. However, generic MLLMs still face two major obstacles in plant disease recognition-insufficient fine-grained visual perception and misalignment between visual and linguistic features-which jointly limit diagnostic accuracy. To address these issues, we propose a Qwen2.5-VL-based full-chain fine-tuning framework termed dual-side synergistic low-rank adaptation. Unlike the mainstream paradigm that freezes the vision encoder, our method injects trainable LoRA adapters into both the vision encoder and the large language model, while establishing end-to-end gradient backpropagation across the entire multimodal pipeline. By using the supervision signal from autoregressive text generation (text-supervised visual learning), the framework directly drives deep optimization of visual representations, thereby enabling coordinated alignment between pixel-level perception and semantic-level understanding. We trained Qwen over CDDM and conducted in-domain (CDDM) and cross-domain (PlantVillage) experiments. The results show that the proposed 7B-parameter model achieves 98.8 and 96.0% diagnostic accuracy under in-domain and cross-domain scenarios, respectively. The recognition accuracy of Qwen in the case of cross-domain only decreases slightly, which demonstrates that the MLLM trained by our method exhibits excellent cross-domain recognition capability. This indicates that our method can significantly improve the robustness and generalization ability of MLLM in complex agricultural scenarios.

Indexed as

dual-side LoRAfull-chain fine-tuningmultimodal large language modelplant disease diagnosisQwen2.5-VL

Identifiers

PMID42452142
PMCPMC13364257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.